Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 39751 - 39775 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Etoposide	Approved Investigational	COA7	65260	downregulated	Etoposide results in decreased expression of COA7 mRNA	1p32.3	A21499
Etoposide	Approved Investigational	CPT2	1376	downregulated	Etoposide results in decreased expression of CPT2 mRNA	1p32.3	A21499
Etoposide	Approved Investigational	CRABP2	1382	upregulated	Etoposide results in increased expression of CRABP2 mRNA	1q23.1	A21863
Etoposide	Approved Investigational	CXCL12	6387	downregulated	Etoposide results in decreased expression of CXCL12 mRNA	10q11.21	A22589
Etoposide	Approved Investigational	CXCL8	3576	upregulated	Etoposide results in increased expression of CXCL8 mRNA	4q13.3	A22590
Etoposide	Approved Investigational	CYP27B1	1594	upregulated	Etoposide results in increased expression of CYP27B1 mRNA	12q14.1	A22454
Etoposide	Approved Investigational	CYP3A4	1576	upregulated	[Etoposide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA	7q22.1	A21466
Etoposide	Approved Investigational	DPYSL4	10570	upregulated	Etoposide results in increased expression of DPYSL4 mRNA	10q26.3	A21863
Etoposide	Approved Investigational	EGFR	1956	downregulated	Etoposide results in decreased expression of EGFR mRNA	7p11.2	A22581
Etoposide	Approved Investigational	EI24	9538	upregulated	Etoposide results in increased expression of EI24 mRNA	11q24.2	A20666
Etoposide	Approved Investigational	EMP1	2012	upregulated	Etoposide results in increased expression of EMP1 mRNA	12p13.1	A21863
Etoposide	Approved Investigational	EMP3	2014	upregulated	Etoposide results in increased expression of EMP3 mRNA	19q13.33	A21863
Etoposide	Approved Investigational	EPM2AIP1	9852	upregulated	Etoposide results in increased expression of EPM2AIP1 mRNA	3p22.2	A20666
Etoposide	Approved Investigational	ERBB2	2064	downregulated	Etoposide results in decreased expression of ERBB2 mRNA	17q12	A22581
Etoposide	Approved Investigational	ERBB3	2065	downregulated	Etoposide results in decreased expression of ERBB3 mRNA	12q13.2	A22581
Etoposide	Approved Investigational	ERBB4	2066	downregulated	Etoposide results in decreased expression of ERBB4 mRNA	2q34	A22581
Etoposide	Approved Investigational	EREG	2069	upregulated	Etoposide results in increased expression of EREG mRNA	4q13.3	A22581
Etoposide	Approved Investigational	F3	2152	upregulated	Etoposide results in increased expression of F3 mRNA	1p21.3	A22591
Etoposide	Approved Investigational	FADS3	3995	upregulated	Etoposide results in increased expression of FADS3 mRNA	11q12.2	A21863
Etoposide	Approved Investigational	FASN	2194	upregulated	Etoposide results in increased expression of FASN mRNA	17q25.3	A6070
Etoposide	Approved Investigational	FDXR	2232	upregulated	Etoposide results in increased expression of FDXR mRNA	17q25.1	A20666
Etoposide	Approved Investigational	FLNC	2318	upregulated	Etoposide results in increased expression of FLNC mRNA	7q32.1	A21863
Etoposide	Approved Investigational	FOXJ2	55810	downregulated	Etoposide results in decreased expression of FOXJ2 mRNA	12p13.31	A21499
Etoposide	Approved Investigational	FZD1	8321	downregulated	Etoposide results in decreased expression of FZD1 mRNA	7q21.13	A21499
Etoposide	Approved Investigational	GADD45A	1647	upregulated	Etoposide results in increased expression of GADD45A mRNA	1p31.3	A21863

Displaying entries 39751 - 39775 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability